Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents. Issue 5 (18th February 2021) - Othman, Tamer A.; Mei, Matthew; Zhang, Jianying; Aldoss, Ibrahim; Stein, Anthony; Forman, Stephen J.; Marcucci, Guido; Pullarkat, Vinod